Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.07.2011 | Case report

Duloxetine withdrawal

Discontinuation syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

A 50-year-old woman was diagnosed with mixed anxiety and depressive disorder with somatoform disorder. She received duloxetine [route not stated] at a dose of 40mg for 124 days, followed by 30mg for 48 days and 20mg for 7 days. Duloxetine was then stopped. She was also receiving zolpidem, which was changed to lorazepam. One day after discontinuation of duloxetine, she developed insomnia, tension and irritability, dizziness, dyspepsia and a crawling sensation on her scalp. Duloxetine was restarted and her symptoms disappeared over the next day.Author Comment “We applied the Naranjo's ADR Causality Assessment scale and found that it could be categorized as Probable only, with a score of six.”
Literatur
1.
Zurück zum Zitat Lahon K, Shetty HM, Paramel A, Sharma G.Duloxetine induced discontinuation syndrome: A case report on drug safety. Journal of Clinical and Diagnostic Research 5: 374-375, No. 2, Apr 2011 - India Lahon K, Shetty HM, Paramel A, Sharma G.Duloxetine induced discontinuation syndrome: A case report on drug safety. Journal of Clinical and Diagnostic Research 5: 374-375, No. 2, Apr 2011 - India
Metadaten
Titel
Duloxetine withdrawal
Discontinuation syndrome: case report
Publikationsdatum
01.07.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113580-00056

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Atorvastatin

Case report

Insulin aspart